Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029903

SVP & Chief Accounting Officer sold 5,841 shares at $3.95 ($23,072)

  • SVP & Chief Accounting Officer acquired 10,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2022-05-15 Grant or award +10,950 176,268 D: show line 1 in the form
Thomsen Jillian B. SVP & Chief Accounting Officer 2022-05-16 Sale −5,841 $3.95 $23,072 170,427 D: show line 2 in the form
Open-market sales · 5,841 sh · avg $3.95 · $23,072
Loading xslF345X03/doc4.xml…